MyMD Pharmaceuticals, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AVIR
|
Atea Pharmaceuticals, Inc. | $3.33 | $311.63 M | -1.9 | 75 | $0 |
 BOLT
|
Bolt Biotherapeutics, Inc. | $0.65 | $29.02 M | -0.46 | 100 | $7.88 M |
 DSGN
|
Design Therapeutics, Inc. | $5.15 | $217.51 M | -3.7 | 57 | $0 |
 EXAI
|
Exscientia plc | $4.62 | $679.46 M | -4.05 | 483 | $19.75 M |
 GOSS
|
Gossamer Bio, Inc. | $1.05 | $124.06 M | -0.65 | 135 | $0 |
 GOVX
|
GeoVax Labs, Inc. | $2.20 | $4.07 M | -0.11 | 17 | $0 |
 ICVX
|
Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 |
 KRON
|
Kronos Bio, Inc. | $0.98 | $44.62 M | -0.37 | 58 | $6.29 M |
 KROS
|
Keros Therapeutics, Inc. | $59.79 | $1.76 B | -9.45 | 149 | $151,000 |
 KZR
|
Kezar Life Sciences, Inc. | $0.80 | $49.85 M | -0.49 | 58 | $7.00 M |
 LGND
|
Ligand Pharmaceuticals Incorporated | $101.31 | $1.46 B | 15.21 | 58 | $131.31 M |
 LRMR
|
Larimar Therapeutics, Inc. | $6.27 | $611.84 M | -9.99 | 42 | $0 |
 LYEL
|
Lyell Immunopharma, Inc. | $1.29 | $619.50 M | -2.7 | 224 | $130,000 |
 LYRA
|
Lyra Therapeutics, Inc. | $0.26 | $19.53 M | -0.27 | 88 | $1.56 M |
 NBY
|
NovaBay Pharmaceuticals, Inc. | $0.68 | $2.93 M | -0.02 | 24 | $14.73 M |
 NVCT
|
Nuvectis Pharma, Inc. | $6.37 | $116.38 M | -4.5 | 13 | $0 |
 ORIC
|
ORIC Pharmaceuticals, Inc. | $10.04 | $595.34 M | -4.91 | 107 | $0 |
 PASG
|
Passage Bio, Inc. | $0.65 | $73.04 M | -0.77 | 58 | $0 |
 REPL
|
Replimune Group, Inc. | $11.90 | $485.18 M | -2.44 | 331 | $0 |
 REVB
|
Revelation Biosciences, Inc. | $0.84 | $3.59 M | -0.05 | 9 | $0 |
 RXRX
|
Recursion Pharmaceuticals, Inc. | $6.17 | $1.96 B | -5.22 | 500 | $44.58 M |
 SRZN
|
Surrozen, Inc. | $11.10 | $35.47 M | -0.6 | 42 | $0 |
 UBX
|
Unity Biotechnology, Inc. | $1.45 | $26.86 M | -0.6 | 19 | $0 |
 XBIO
|
Xenetic Biosciences, Inc. | $4.24 | $6.02 M | -1.33 | 4 | $2.54 M |
 YS
|
YS Biopharma Co., Ltd. | $1.02 | $192.09 M | -1.82 | 773 | $687.20 M |